DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank-check company targeting the life science and healthcare technology sector. The SPAC filed a 10-Q with the SEC on November 10, 2022, reflecting its operational status as a pre-combination vehicle actively seeking an acquisition target. DALS completed its initial public offering in 2022 and, like other sector-focused SPACs of that vintage, positioned itself to capitalize on deal opportunities across biopharma, med-tech, and life science infrastructure. As of the filing date, the company remained in its search phase with no definitive business combination announced. Sign up at SpacDesk for complete filing history, timeline data, and real-time status updates on DALS and hundreds of other active SPACs.